Epidemiology

You have full text access to this OnlineOpen article

Self-reported health and use of health care services in long-term cancer survivors

  1. Carina Nord1,†,*,
  2. Arnstein Mykletun2,
  3. Lene Thorsen1,
  4. Trine Bjøro3,
  5. Sophie D. Fosså1

Article first published online: 12 NOV 2004

DOI: 10.1002/ijc.20713

Issue

International Journal of Cancer

International Journal of Cancer

Volume 114, Issue 2, pages 307–316, 20 March 2005

Additional Information

How to Cite

Nord, C., Mykletun, A., Thorsen, L., Bjøro, T. and Fosså, S. D. (2005), Self-reported health and use of health care services in long-term cancer survivors. Int. J. Cancer, 114: 307–316. doi: 10.1002/ijc.20713

Author Information

  1. 1

    Department of Clinical Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway

  2. 2

    Centre for Health Promotion, Faculty of Psychology, University of Bergen, Bergen, Norway

  3. 3

    Department of Central Laboratory, The Norwegian Radium Hospital, Montebello, Oslo, Norway

  1. †

    Fax: +47-22-93-45-53

*Department of Clinical Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway

Publication History

  1. Issue published online: 18 JAN 2005
  2. Article first published online: 12 NOV 2004
  3. Manuscript Accepted: 16 AUG 2004
  4. Manuscript Received: 18 MAY 2004

Funded by

  • Norwegian Foundation of Health and Rehabilitation
  • The Norwegian Cancer Society

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (142K)

References

  • 1
    Cancer Registry of Norway. Cancer in Norway 1999. 2002.
  • 2
    Moller TR, Garwicz S, Barlow L, Falck-Winther J, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001; 19: 3173–81.
  • 3
    Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 1999; 4: 45–54.
  • 4
    Schultz PN, Beck ML, Stava C, Vassilopoulou-Sellin R. Health profiles in 5836 long-term cancer survivors. Int J Cancer 2003; 104: 488–95.
    Direct Link:
  • 5
    Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003; 58: 82–91.
  • 6
    Meinardi MT, Gietema JA, van Veldhuisen DJ, van der Graaf WT, de Vries EG, Sleijfer DT. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev 2000; 26: 429–47.
  • 7
    Talvensaari KK, Lanning M, Tapanainen P, Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996; 81: 3051–5.
  • 8
    Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes R M, Wist E, Fossa SD. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 2003; 44: 322–8.
  • 9
    Nord C, Fossa SD, Egeland T. Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer 2003; 88: 36–41.
  • 10
    Feig SA. Second malignant neoplasms after successful treatment of childhood cancers. Blood Cells Mol Dis 2001; 27: 662–6.
  • 11
    Wanderas EH, Fossa SD, Tretli S. Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 1997; 33: 253–62.
  • 12
    Travis LB. Therapy-associated solid tumors. Acta Oncol 2002; 41: 323–33.
  • 13
    Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429–39.
  • 14
    Blanchard CM, Denniston MM, Baker F, Ainsworth SR, Courneya KS, Hann DM, Gesme DH, Reding D, Flynn T, Kennedy JS. Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav 2003; 27: 246–56.
  • 15
    Holmen J, Midthjell K, Kruger O, Langhammer A., Lingaas Holmen T, Bratberg G H, Vatten LJ, Lund-Larsen PG. The Nord-Trøndelag Health Study 1995–1997 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13: 19–32.
  • 16
    www.kreftregisteret.no. Det Norske Kreftregisteret (The Cancer Registry of Norway). 2003.
  • 17
    Thorsen L, Nystad W, Dahl O, Klepp O, Bremens R M, Wist E, Fossa SD. The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer 2003; 39: 1216–21.
  • 18
    Cancer Registry of Norway. Cancer in Norway 2001. Oslo, Norway, 2004.
  • 19
    www.hunt.ntnu.no. The Nord-Trøndelag Health Survey, Norway. 2003.
  • 20
    Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 2003; 21: 1249–54.
  • 21
    Deimling GT, Kahana B, Bowman KF, Schaefer ML. Cancer survivorship and psychological distress in later life. Psychooncology 2002; 11: 479–94.
    Direct Link:
  • 22
    Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol 2002; 20: 4581–90.
  • 23
    Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999; 17: 253–61.
  • 24
    Stone HB, Coleman CN, Anscher MS, McBride William H. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003; 4: 529–36.
  • 25
    Maduro JH, Pras E, Willemse PHB, de Vries EGE. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 2003; 29: 471–88.
  • 26
    Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37: 3–11.
  • 27
    Fasth S, Hedlund H, Svaninger G, Oresland T, Hulten L. Functional results after subtotal colectomy and caecorectal anastomosis. Acta Chir Scand 1983; 149: 623–7.
  • 28
    Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 2000; 18: 1570–93.
  • 29
    Compston JE. Sex steroids and bone. Physiol Rev 2001; 81: 419–47.
  • 30
    Oefelein MG, Ricchuiti V, Conrad W, Seftel A, Bodner D, Goldman H, Resnick M. Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer. J Urol 2001; 166: 1724–8.
  • 31
    Tai P, Hammond A, Dyk JV, Stitt L, Tonita J, Coad T, Radwan J. Pelvic fractures following irradiation of endometrial and vaginal cancers-a case series and review of literature. Radiother Oncol 2000; 56: 23–8.
  • 32
    Forsmo S, Schei B, Langhammer A, Forsen L. How do reproductive and lifestyle factors influence bone density in distal and ultradistal radius of early postmenopausal women? The Nord-Trondelag Health Survey, Norway. Osteoporos Int 2001; 12: 222–9.
  • 33
    Morello KC, Wurz GT, DeGregorio MW. SERMs: current status and future trends. Crit Rev Oncol Hematol 2002; 43: 63–76.
  • 34
    Jordan VC, Gapstur S, Morrow M. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 2001; 93: 1449–57.
  • 35
    Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol 2004; 22: 640–7.
  • 36
    Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003; 21: 1513–23.
  • 37
    Meinardi MT, Gietema JA, van der Graaf WT, van Veldhuisen DJ, Runne MA, Sluiter WJ, de Vries EG, Willemse PB, Mulder NH, van den Berg MP, Koops HS, Sleijfer DT. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 2000; 18: 1725–32.
  • 38
    Lund MB, Ihlen H, Voss BM, Abrahamsen AF, Nome O, Kongerud J, Stugaard M, Forfang K. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996; 75: 591–5.
  • 39
    Lund MB, Kongerud J, Boe J, Nome O, Abrahamsen AF, Ihlen H, Forfang K. Cardiopulmonary sequelae after treatment for Hodgkin's disease: increased risk in females? Ann Oncol 1996; 7: 257–64.
  • 40
    Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 2003: 61: 32–8.
  • 41
    Hammarsten J, Hogstedt B. Calculated fast-growing benign prostatic hyperplasia: a risk factor for developing clinical prostate cancer. Scand J Urol Nephrol 2002; 36: 330–8.
  • 42
    Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Hypertension, heart rate, use of antihypertensives, and incident prostate cancer. Ann Epidemiol 2001; 11: 534–42.
  • 43
    Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003; 21: 167–92.
  • 44
    Newton HB. Neurologic complications of systemic cancer. Am Fam Physician 1999; 59: 878–86.
  • 45
    Haheim LL, Holme I, Hjermann I, Leren P. Risk factors of stroke incidence and mortality: a 12-year follow-up of the Oslo Study. Stroke 1993; 24: 1484–9.
  • 46
    Khoo VS, Liew KH, Crennan EC, D'Costa IM, Quong G. Thyroid dysfunction after mantle irradiation of Hodgkin's disease patients. Australas Radiol 1998; 42: 52–7.
    Direct Link:
  • 47
    Knobel H, Havard-Loge J, Brit-Lund M, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 2001; 19: 3226–33.
  • 48
    Evensen JF, Fossa SD, Kjellevold K, Lien HH. Testicular seminoma: analysis of treatment and failure for stage II disease. Radiother Oncol 1985; 4: 55–61.
  • 49
    Derakhshani P, Klotz T, Heidenreich A, Engelmann U. Diffuse metastasized testicular teratoma and paraneoplastic thyreotoxicosis. Case report and literature review. Urol Int 1999; 63: 265–7.
  • 50
    Kellner O, Voigt W, Schneyer U, Dempke W, Schmoll HJ. HCG induced hyperthyreosis in germ cell cancer. Anticancer Res 2000; 20: 5135–8.
  • 51
    Cain HJ, Pannall PR, Kotasek D, Norman RJ. Choriogonadotropin-mediated thyrotoxicosis in a man. Clin Chem 1991; 37: 1127–31.
  • 52
    Verbeek J, Spelten E, Kammeijer M, Sprangers M. Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physicians. Occup Environ Med 2003; 60: 352–7.
  • 53
    Thomas SF, Glynne-Jones R, Chait I, Marks DF. Anxiety in long-term cancer survivors influences the acceptability of planned discharge from follow-up. Psychooncology 1997; 6: 190–6.
  • 54
    Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res 2002; 105: 53–7.
  • 55
    Gionet NJ, Godin G. Self-reported exercise behavior of employees: a validity study. J Occup Med 1989; 31: 969–73.
  • 56
    Schechtman KB, Barzilai B, Rost K, Fisher E-BJ. Measuring physical activity with a single question. Am J Public Health 1991; 81: 771–3.
  • 57
    Krokstad S, Kunst AE, Westin S. Trends in health inequalities by educational level in a Norwegian total population study. J Epidemiol Community Health 2002; 56: 375–80.
  • 58
    Statistics Norway. www.ssb.no. 2004.
View Full Article (HTML) Get PDF (142K)